Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($1.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.22) by ($0.01), FiscalAI reports. Crinetics Pharmaceuticals had a negative net margin of 2,747.18% and a negative return on equity of 46.02%. The business had [...]
Crinetics Pharmaceuticals (NASDAQ:CRNX) Releases Earnings Results, Misses Expectations By $0.01 EPS
